Aids Vaccine Advocacy Coalition Inc

ACCELERATE THE ETHICAL DEVELOPMENT OF EFFECTIVE HIV (CONTINEUD ON SCHEDULE O)CONTINUED: PREVENTION OPTIONS AND ENSURE ACCESS TO THOSE OPTIONS FOR EVERYONE WHO NEEDS THEM AS PART OF A COMPREHENSIVE INTEGRATED PATH TO GLOBAL HEALTH EQUITY.

PRODUCT INTRODUCTION AND ACCESS: THE PRODUCT INTRODUCTION PROGRAM IS DESIGNED TO IDENTIFY AND ANTICIPATE NEEDS AND GAPS AND PROVIDE TARGETED TOOLS, SUPPORT AND PLATFORMS TO EXPAND ACCESS TO HIV/AIDS PREVENTION. THE PROGRAM FOCUSES ON: SUCCESSFUL SCALE-UP AND INTRODUCTION IN THREE PRIORITY COUNTRIES FROM THE OUTSET; DEVELOP ADAPTABLE AND SCALABLE TOOLS TO SUPPORT OTHER COUNTRIES; SUPPORT THE DEVELOPMENT OF MARKETABLE PRODUCTS IN THE HIV PREVENTION AND SEXUAL AND REPRODUCTIVE HEALTH RESEARCH PIPELINE; AND CREATE A FLEXIBLE MECHANISM TO ASSIST PRODUCT DEVELOPERS, FUNDERS AND COUNTRY PROGRAMS TO IDENTIFY AND ADDRESS BARRIERS TO IMPROVED PRODUCTS AND ACCELERATED INTRODUCTION. PROJECTS ARE IMPLEMENTED IN COLLABORATION WITH A NETWORK OF FUNDERS, (CONTINUED ON SCHEDULE O)CONTINUED: PRODUCT DEVELOPERS AND GOVERNMENTAL AND NON-GOVERNMENTAL ORGANIZATIONS INCLUDING THE BILL AND MELINDA GATES FOUNDATION, CHILDRENS INVESTMENT FUND FOUNDATION, WORLD HEALTH ORGANIZATION, POPULATION COUNCIL, VIATRIS, MANN GLOBAL HEALTH, MEDICINES360, USAID, CATALYST GLOBAL, HIV PREVENTION TRIALS NETWORK, AND CLINTON HEALTH ACCESS INITATIVE.

PROGRAMS ARE GLOBAL MOVEMENT AND PROGRAM MANAGEMENT AND COORDINATION.

RESEARCH ENGAGEMENT AND PREPAREDNESS: RESEARCH PREPAREDNESS IS DESIGNED TO SHAPE THE R&D ENVIRONMENT THROUGH ADVOCACY FOR INVESTMENT, POLITICAL SUPPORT, AND GOOD PARTICIPATORY PRACTICE. AVAC TRACKS AND TRANSLATES BOTH COMMUNITY ADVOCACY AND COMPLEX SCIENCE TO MAKE THE SCIENCE ACCESSIBLE AND POSITION COMMUNITY PRIORITIES AT THE CENTER OF GLOBAL HEALTH. AVAC IMPROVED TRIAL DESIGN AND CONDUCT BY BRINGING TOGETHER RESEARCHERS, TRIAL SITE STAFF, CIVIL SOCIETY, POLICYMAKERS, TRIAL PARTICIPANTS, AND COMMUNITIES TO CENTER PERSPECTIVES OF AFFECTED COMMUNITIES IN RESEARCH. AVAC DEVELOPED MATERIALS AND DOCUMENTS RELATING TO THE PREVENTION OF HIV/AIDS; CONVENED MULTIPLE MEETINGS WITH STAKEHOLDERS SUCH AS RESEARCHERS AND CIVIL SOCIETY LEADERS TO DISCUSS RESEARCH FINDINGS; (CONTINUED ON SCHEDULE O)CONTINUED: SUPPORTED ADVOCACY NETWORKS AND MAJOR AFRICA-LED INITATIVES TO CALL FOR CHOICE AND EQUITY IN HIV PREVENTION INVESTMENTS GLOBALLY; AND ISSUED SUBGRANTS TO MORE THAN 13 PARTNERS IN THE US AND AFRICA UNDER THE HIV BIOMEDIAL PREVENTION RESEARCH PROJECT FUNDED BY USAID IDENTIFY AND MITIGATE OR ELIMINATE BARRIERS TO THE DEVELOPMENT OF AND ACCESS TO NEW HIV VACCINES AND OTHER PREVENTION OPTIONS; AND PROMOTE INCREASED RESOURCES FOR HIV VACCINE AND PREVENTION RESEARCH BY DONORS INCLUDING GOVERNMENT AGENCIES.

POLICY ADVOCACY: AVAC WORKS WITH PARTNERS AND POLICYMAKERS TO DEVELOP AND PURSUE BOLD NATIONAL, REGIONAL, AND INTERNATIONAL AGENDAS THAT ADVANCE HIV PREVENTION AND GLOBAL HEALTH EQUITY AND LAY A SOLID FOUNDATION FOR GLOBAL HEALTH SECURITY AGAINST FUTURE PANDEMICS. AVAC HELPS TO SHAPE GLOBAL HEALTH SPENDING AND PLANNING FOR HIV PREVENTION BY MOBILIZING TO ENSURE PROGRAMS, PRODUCTS AND POLICIES ARE EVIDENCE-BASED, INCLUSIVE AND EFFECTIVE. WITH A NETWORK OF PARTNERS, AVAC IDENTIFIES CRITICAL POLICY NEEDS AND DEVELOPS STRATEGIC CAMPAIGNS TO ADVANCE HIV PREVENTION WITH A FOCUS ON ENSURING A RICH R&D PIPELINE WITH ROLLOUT PLANS TO REACH AFFECTED COMMUNITIES. AVAC AND PARTNERS FOUNDED AND SUPPORT THE GLOBAL AIDS POLICY PARTNERSHIP AND FEDERAL AIDS POLICY (CONTINUED ON SCHEDULE O)CONTINUED: PARTNERSHIP TO CREATE DIVERSE COALITIONS THAT WORK TO MAINTAIN AND EXPAND WELL-RESOURCED, EVIDENCE-BASED HIV PREVENTION AND TREATMENT PROGRAMMING AND FUNDING AT US AND INTERNATIONAL LEVELS. THROUGH THE COMPASS PROGRAM, AVAC WORKS WITH PARTNERS TO CHANGE THE HIV RESPONSE THROUGH HIGH-IMPACT, DATA-INFORMED TRANSNATIONAL ADVOCACY CAMPAIGNS LED BY CIVIL SOCIETY ORGANIZATIONS REPRSENTING COMMUNITIES MOST IMPACTED BY HIV. THESE CAMPAIGNS INCREASE CIVIL SOCIETY IMPACT ON HIV-RELATED POLICIES, PROGRAMS AND APPROACHES TO PREVENTION.